Published in Transplant Proc on March 01, 1979
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
High molecular weight antigens present on human T cells. Proc Natl Acad Sci U S A (1980) 0.82
A human genome diversity cell line panel. Science (2002) 14.11
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A (1993) 2.91
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 2.61
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science (1993) 1.98
Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48
Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 alpha and CD8 beta chains. Blood (1992) 1.45
The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum (2002) 1.43
Mitochondrial DNA polymorphism in four Sardinian villages. Ann Hum Genet (1988) 1.39
Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol (1999) 1.39
Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J Immunol (1988) 1.26
Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc (2001) 1.24
Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature (1989) 1.13
Linkage of Chido and HL-A. Tissue Antigens (1974) 1.12
HLA-B locus sequence-based typing. Tissue Antigens (1999) 1.10
Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology (1997) 1.04
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations. Ann Hum Genet (1994) 0.97
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness. Tissue Antigens (1997) 0.97
A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature (1989) 0.97
HLA-DR typing by radioimmunoassay. Transplantation (1980) 0.96
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones. Clin Exp Immunol (2001) 0.94
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol (2000) 0.93
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood (1991) 0.92
The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Immunogenetics (1983) 0.92
Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. Eur J Cancer (2003) 0.90
Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model. J Immunol (2001) 0.89
HLA-C high resolution typing: analysis of exons 2 and 3 by sequence based typing and detection of polymorphisms in exons 1-5 by sequence specific primers. Tissue Antigens (1998) 0.89
The production of anti HL-A cytotoxic antisera through planned immunization by intravenous injection of small aliquots of whole blood. I. Immunization of unrelated recipients. Tissue Antigens (1972) 0.88
An ID card for tumour cell lines: HLA typing can help. Lancet Oncol (2001) 0.88
Frequency of DPB1*0401 is significantly decreased in patients with allergic asthma in a mulatto population. Hum Immunol (1991) 0.87
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE. J Rheumatol (2000) 0.86
Evaluation of a new tumor-associated antigen in pancreatic cancer. Digestion (1984) 0.86
HL-A unresponsiveness induced by weekly transfusions of small aliquots of whole blood. Transplantation (1974) 0.86
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines. Cancer Res (1999) 0.86
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus (2000) 0.86
Investigation of HLA class I downregulation in breast cancer by RT-PCR. Hum Immunol (2001) 0.86
A safe blood transfusion procedure for immunization against major histocompatibility complex determinants in man. Transplantation (1978) 0.86
Antigen-specific antibody response induced in cultures of human blood lymphocytes in presence of polyethylene glycol. Eur J Immunol (1981) 0.85
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus (2003) 0.84
T cell proliferation is blocked by indoleamine 2,3-dioxygenase. Transplant Proc (2001) 0.84
A new approach to HLA-DPB1 typing combining DNA heteroduplex analysis with allele-specific amplification and enzyme restriction. Immunogenetics (1992) 0.83
Activation-related differences in HLA class I-bound peptides: presentation of an IL-1 receptor antagonist-derived peptide by activated, but not resting, CD4+ T lymphocytes. J Immunol (1997) 0.82
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. Int J Cancer (1991) 0.82
A rapid screening method to detect nonsense and frameshift mutations: identification of disease-causing APC alleles. Cancer Res (1993) 0.82
Genomic PCR-SSCP analysis of the metastasis associated NM23-H1 (NME1) gene: a study on colorectal cancer. Anticancer Res (1994) 0.81
Molecular analysis of HLA-DQ A alleles in coeliac disease lack of a unique disease-associated sequence. Clin Exp Immunol (1991) 0.81
Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities. Hum Immunol (1981) 0.81
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment. Tissue Antigens (2000) 0.81
Markers of human T cell subsets identified by alloantisera. J Immunol (1979) 0.80
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Bone Marrow Transplant (1997) 0.80
Molecular characterization and applications of recombinant scFv antibodies to CD152 co-stimulatory molecule. Tissue Antigens (2000) 0.80
Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules. Br J Cancer (1999) 0.80
HLA polymorphism in a Mataco South American Indian tribe: serology of class I and II antigens. Molecular analysis of class II polymorphic variants. Hum Immunol (1992) 0.79
HLA antigens in essential mixed cryoglobulinemia. Arthritis Rheum (1981) 0.79
Southern blot and microfingerprinting analysis of two DR7 haplotypes. Immunogenetics (1986) 0.79
HLA segregation of human T-cell subpopulation markers. Hum Immunol (1981) 0.79
DNA typing of DQ and DR alleles in IgA-deficient subjects. Eur J Immunogenet (1995) 0.79
Reassessment of HLA association with celiac disease in special reference to the DP association. Hum Immunol (1990) 0.78
The human antibody repertoire: heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigens. Mol Immunol (1995) 0.78
Anti-CTLA-4 human scFv antibodies prevent T-cell activation in transplantation. Transplant Proc (2001) 0.78
Serologically detectable polymorphism of the HLA-DC alpha-subunit. J Immunol (1984) 0.78
Human monoclonal antibody MP8 detects a supertypic determinant encoded by DPB alleles DPB2.1, DPB3, DPB4.2, DPB8, DPB9, DPB10, and DPB14. Immunogenetics (1989) 0.78
DNA typing of HLA-DR beta chain genes can discriminate between undetected alleles and real homozygotes. Immunogenetics (1987) 0.78
DNA typing of HLA-DQ alleles by gene amplification of DQA and DQB variable exons: analysis of DQA/DQB haplotypes. Eur J Immunogenet (1992) 0.78
Correlation between steroid hormone receptors and prognostic factors in human breast cancer. Oncology (1987) 0.78
Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probes. Bone Marrow Transplant (1992) 0.78
Human lymphoblastoid cell lines secreting antibodies with restricted HLA specificity. Immunogenetics (1987) 0.78
Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants. Transplant Proc (1992) 0.78
HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencing. Tissue Antigens (1997) 0.78
Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer. Biomed Pharmacother (1985) 0.77
HLA-A, -B, -C genotyping and expression in human nonlymphoid tumor cell lines. J Immunother (1999) 0.77
Critical role of HLA-DR beta 1 residue 58 in multiple polymorphic epitopes recognized by xenogeneic and allogeneic antibodies. Hum Immunol (1992) 0.77
The HLA-B*2709 subtype in a patient with undifferentiated spondarthritis. Ann Rheum Dis (2000) 0.77
Alport syndrome: HLA association and kidney graft outcome. Eur J Immunogenet (2004) 0.77
Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies. Clin Exp Immunol (2004) 0.77
HLA-C sequence based typing: nucleotide analysis from exon 1 through exon 8. Identification of a new allele: Cw*0718. Tissue Antigens (2003) 0.77
Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanoma. J Immunogenet (1987) 0.77
Biochemical analysis of HLA class I subunits expression in breast cancer tissues. Hum Immunol (2000) 0.77
Human anti-HLA monoclonal antibodies: production, characterization, and application. Hum Immunol (1988) 0.77
A novel approach to human anti-HLA mABs production: use of phage display libraries. Hum Immunol (1997) 0.76
Analysis of HLA-G expression in tumor cell lines. Transplant Proc (1999) 0.76
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability. Hum Immunol (2000) 0.76
Characterization of a new HLA-C allele in a Caucasian Italian family by sequence-based typing: HLA-Cw*0730. Tissue Antigens (2006) 0.76
Cellular mechanisms of exogenous peptide binding to HLA class II molecules in B cells. Cell Immunol (1994) 0.75
Apparent maternal exclusion due to Duffy phenotypes. Haematologica (1991) 0.75
Characteristics of the cytosol-synthesized proteins generating class-I-bound peptides. Hum Immunol (1994) 0.75
Human anti-HLA-DQw2 monoclonal antibody secreted by an Epstein-Barr-virus--transformed lymphoblastoid cell line: assessment of the monoclonality, allospecificity, and target. Hum Immunol (1989) 0.75
[Allelic variations of DPB1, DQA1, DQB1 and DRB1 and rheumatoid arthritis: further genetic and statistical considerations]. Ann Ital Med Int (1995) 0.75
Genotypic analysis of engraftment in thalassemia following bone marrow transplantation using synthetic oligonucleotides. Bone Marrow Transplant (1989) 0.75
Serological detection and molecular localization of allelic HLA-DP supertypic epitopes. Eur J Immunol (1989) 0.75
Molecular oncology: from basic research towards clinical application. Eur J Cancer Prev (1993) 0.75
Polymorphism of the HLA-DP beta region detected by Southern blot hybridization. Hum Immunol (1990) 0.75
Proliferation and immunoglobulin secretion of lymphoblastoid cell lines are differently affected by soluble cytokines. Cell Prolif (1994) 0.75
Shared epitopes of the HLA-DR10 molecule recognized by murine and human mAbs. Eur J Immunogenet (1993) 0.75
HLA-DP typing by DNA amplification and hybridization with specific oligonucleotides. Hum Immunol (1989) 0.75